Leading by Example: A Spotlight on Each of Waisman’s Directors

The Waisman Center has a long history of excellent and remarkable leadership. Each director of the center has played a pivotal role in advancing Waisman’s research, service, training, and outreach efforts. This article highlights the Waisman Center’s directors, both past and present, that have allowed the center to proudly follow its mission of advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.

Building bridges between disciplines: Marsha Mailick’s interdisciplinary research and leadership at the Waisman Center

Multiple angles of vision all focused on a common question is what attracted Marsha Mailick, PhD, emeritus vice chancellor for research and graduate education at the University of Wisconsin-Madison, to the Waisman Center more than 35 years ago.

Transitioning Together helps adolescents with autism and their families gear up for adulthood

The Transitioning Together curriculum is adaptable to different settings, including clinical settings and school settings. Because of its unique design and positive impacts, it has been adopted in 11 states outside of Wisconsin, and Canada.

Understanding autism from the minute to the masses: Autism research at the Waisman Center

Autism spectrum disorder (ASD) is an intricate and complicated diagnosis. The spectrum of presentations and severity is as expansive as the theorized causes. Autism’s complexity and breadth of impacts on a person’s life means that it has a multitude of facets to investigate.

Waisman postdoctoral training program: Training the next generation of IDD researchers

The first two years of the grant provided funding for two seminars in an academic year, but in a short span, seeing the tangible benefits these had, they expanded from two lectures a year, to two a month.

Marsha R. Mailick, PhD – Slide of the Week

 Fragile X syndrome (FXS), the most prevalent inherited cause of intellectual disability, remains under-diagnosed in the general population. Clinical studies have shown that individuals with FXS have a complex health profile leading to unique clinical needs. However, the full impact of this X-linked disorder on the health of affected individuals is unclear and the prevalence of co-occurring conditions is unknown.